tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market
NWPHF
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports

Newron Pharmaceuticals SpA (NWPHF) Stock News & Sentiment

Compare
9 Followers
Newron Pharmaceuticals’ Evenamide Advances with ENIGMA-TRS 2 Trial: Analyst Reiterates Buy Rating
Premium
Ratings
Newron Pharmaceuticals’ Evenamide Advances with ENIGMA-TRS 2 Trial: Analyst Reiterates Buy Rating
2d ago
Newron Pharmaceuticals Launches Phase III Study for Schizophrenia Treatment
Premium
Company Announcements
Newron Pharmaceuticals Launches Phase III Study for Schizophrenia Treatment
5d ago
Newron Pharmaceuticals’ Phase III Study on Evenamide: A Potential Game-Changer for Treatment-Resistant Schizophrenia
Premium
Company Announcements
Newron Pharmaceuticals’ Phase III Study on Evenamide: A Potential Game-Changer for Treatment-Resistant Schizophrenia
2M ago
NWPHF
Newron Pharmaceuticals Advances Evenamide for Schizophrenia Treatment
Premium
Company Announcements
Newron Pharmaceuticals Advances Evenamide for Schizophrenia Treatment
2M ago
Newron Pharmaceuticals Advances Evenamide Development with Positive H1 2025 Results
Premium
Company Announcements
Newron Pharmaceuticals Advances Evenamide Development with Positive H1 2025 Results
3M ago
Newron Pharmaceuticals Advances Evenamide Phase III Trials for Schizophrenia
Premium
Company Announcements
Newron Pharmaceuticals Advances Evenamide Phase III Trials for Schizophrenia
3M ago
Newron Pharmaceuticals Advances Evenamide for Schizophrenia Treatment
Premium
Company Announcements
Newron Pharmaceuticals Advances Evenamide for Schizophrenia Treatment
3M ago
More NWPHF News >

NWPHF News on the Web

Newron Pharmaceuticals Advances Evenamide for Schizophrenia Treatment
TipRanks News
Neutral
Newron Pharmaceuticals Advances Evenamide Development with Positive H1 2025 Results
TipRanks News
Neutral
Newron Pharmaceuticals Advances Evenamide Phase III Trials for Schizophrenia
TipRanks News
Neutral
Newron Pharmaceuticals Advances Evenamide for Schizophrenia Treatment
TipRanks News
Neutral
Newron Pharmaceuticals to Participate in a Fireside Chat at the 37th Annual ROTH Conference
Yahoo Finance
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NWPHF’s Media Buzz Sentiment?
Currently, no data Available
What is NWPHF’s weekly average amount of articles?
Currently, no data Available
What is NWPHF’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
XCURExicure
SCLPScancell Holdings
WVEWave Life Sciences
STAAStaar Surgical
KYMRKymera Therapeutics
Showing the stocks with the most bullish news sentiment over the past week